StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Qiagen's price to book ratio was 2.9× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 2.0× to 4.9×, with a median of 3.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×−0.1
2025Dec 31, 20253.0×+0.3
2024Dec 31, 20242.7×−0.3
2023Dec 29, 20233.0×−0.9
2022Dec 30, 20223.9×−1.0
2021Dec 31, 20214.9×−0.1
2020Dec 31, 20205.0×+1.8
2019Dec 31, 20193.2×−0.2
2018Dec 31, 20183.3×+0.3
2017Dec 29, 20173.0×+0.2
2016Dec 30, 20162.7×+0.1
2015Dec 31, 20152.7×+0.5
2014Dec 31, 20142.2×+0.0
2013Dec 31, 20132.2×+0.4
2012Dec 31, 20121.8×+1.8
2011Dec 30, 20110.0×–

More Qiagen figures

See a number that looks wrong?